{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:55:41Z","timestamp":1790214941832,"version":"4.1.0"},"reference-count":165,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2014.00169","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T14:46:29Z","timestamp":1413297989000},"source":"Crossref","is-referenced-by-count":45,"title":["Metabolism, Energetics, and Lipid Biology in the Podocyte \u00e2\u20ac\u201c Cellular Cholesterol-Mediated Glomerular Injury"],"prefix":"10.3389","volume":"5","author":[{"given":"Sandra","family":"Merscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Pedigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando J.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/71724","article-title":"Getting a foothold in nephrotic syndrome","volume":"24","author":"Somlo","year":"2000","journal-title":"Nat Genet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7962","DOI":"10.1073\/pnas.96.14.7962","article-title":"Nephrin is specifically located at the slit diaphragm of glomerular podocytes","volume":"96","author":"Ruotsalainen","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B3","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1681\/ASN.V10112440","article-title":"Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm","volume":"10","author":"Tryggvason","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1097-2765(00)80057-X","article-title":"Positionally cloned gene for a novel glomerular protein \u00e2\u20ac\u201c nephrin \u00e2\u20ac\u201c is mutated in congenital nephrotic syndrome","volume":"1","author":"Kestil\u00c3\u00a4","year":"1998","journal-title":"Mol Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/74166","article-title":"NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome","volume":"24","author":"Boute","year":"2000","journal-title":"Nat Genet"},{"key":"B6","doi-asserted-by":"crossref","first-page":"F785","DOI":"10.1152\/ajprenal.2000.279.4.F785","article-title":"CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere","volume":"279","author":"Li","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1106215","article-title":"A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis","volume":"308","author":"Winn","year":"2005","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/73456","article-title":"Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis","volume":"24","author":"Kaplan","year":"2000","journal-title":"Nat Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"17079","DOI":"10.1073\/pnas.0607465103","article-title":"Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels","volume":"103","author":"Huber","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1681\/ASN.2008070694","article-title":"Lipid-protein interactions along the slit diaphragm of podocytes","volume":"20","author":"Schermer","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1172\/JCI0216452","article-title":"Consequences of cellular cholesterol accumulation: basic concepts and physiological implications","volume":"110","author":"Tabas","year":"2002","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"11603","DOI":"10.1073\/pnas.90.24.11603","article-title":"SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element","volume":"90","author":"Hua","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0092-8674(05)80095-9","article-title":"SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene","volume":"75","author":"Yokoyama","year":"1993","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"11041","DOI":"10.1073\/pnas.96.20.11041","article-title":"A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood","volume":"96","author":"Brown","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1139\/o03-090","article-title":"Molecular regulation of SREBP function: the Insig-SCAP connection and isoform-specific modulation of lipid synthesis","volume":"82","author":"McPherson","year":"2004","journal-title":"Biochem Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"a004754","DOI":"10.1101\/cshperspect.a004754","article-title":"Regulation of cholesterol and fatty acid synthesis","volume":"3","author":"Ye","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"19316","DOI":"10.1073\/pnas.0910916106","article-title":"Cyclodextrin overcomes deficient lysosome-to-endoplasmic reticulum transport of cholesterol in Niemann-Pick type C cells","volume":"106","author":"Abi-Mosleh","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B19","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1172\/JCI200216500","article-title":"Intracellular cholesterol transport","volume":"110","author":"Maxfield","year":"2002","journal-title":"J Clin Invest"},{"key":"B20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0021-9150(99)00155-0","article-title":"Cytotoxic cholesterol is generated by the hydrolysis of cytoplasmic cholesteryl ester and transported to the plasma membrane","volume":"146","author":"Kellner-Weibel","year":"1999","journal-title":"Atherosclerosis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.1074\/jbc.270.11.5772","article-title":"Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol","volume":"270","author":"Warner","year":"1995","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"42468","DOI":"10.1074\/jbc.M101419200","article-title":"Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway","volume":"276","author":"Yao","year":"2001","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1586\/erc.11.16","article-title":"Macrophage cholesterol homeostasis and metabolic diseases: critical role of cholesteryl ester mobilization","volume":"9","author":"Ghosh","year":"2011","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000327317","article-title":"Lipid abnormalities in patients with chronic kidney disease","volume":"171","author":"Keane","year":"2011","journal-title":"Contrib Nephrol"},{"key":"B26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/014107680009300406","article-title":"Lipid abnormalities in renal disease","volume":"93","author":"Majumdar","year":"2000","journal-title":"J R Soc Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000321845","article-title":"Lipid disorders and their relevance to outcomes in chronic kidney disease","volume":"31","author":"Vaziri","year":"2011","journal-title":"Blood Purif"},{"key":"B28","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJM198208053070601","article-title":"Increased lipoprotein-remnant formation in chronic renal failure","volume":"307","author":"Nestel","year":"1982","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5414\/CNP73180","article-title":"NMR identifies atherogenic lipoprotein abnormalities in early diabetic nephropathy that are unrecognized by conventional analysis","volume":"73","author":"Al-Shahrouri","year":"2010","journal-title":"Clin Nephrol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000321508","article-title":"Estimation of oxidative stress markers in chronic kidney disease","volume":"34","author":"Kuchta","year":"2011","journal-title":"Kidney Blood Press Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1681\/ASN.2014010062","article-title":"HDL in CKD: how good is the \u00e2\u20ac\u0153good cholesterol?\u00e2\u20ac\u009d","volume":"25","author":"de Boer","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12290","article-title":"Acquired lcat deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease","author":"Calabresi","year":"2014","journal-title":"J Intern Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1016\/j.febslet.2010.04.047","article-title":"Defective cholesterol trafficking in Niemann-Pick C-deficient cells","volume":"584","author":"Peake","year":"2010","journal-title":"FEBS Lett"},{"key":"B34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1681\/ASN.V85820","article-title":"Apolipoprotein E sendai (arginine 145 \u00e2\u20ac\u201c >proline): a new variant associated with lipoprotein glomerulopathy","volume":"8","author":"Oikawa","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"16904","DOI":"10.1074\/jbc.M010955200","article-title":"Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes","volume":"276","author":"Le Lay","year":"2001","journal-title":"J Biol Chem"},{"key":"B37","first-page":"55N","article-title":"Cholesterol and lipid disturbances in renal disease: the natural history of uremic dyslipidemia and the impact of hemodialysis and continuous ambulatory peritoneal dialysis","volume":"87","author":"Avram","year":"1989","journal-title":"Am J Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1056\/NEJM199008303230905","article-title":"Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome","volume":"323","author":"Joven","year":"1990","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"B39","first-page":"S70","article-title":"Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins","volume":"14","author":"Wheeler","year":"2001","journal-title":"J Nephrol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0272-6386(12)80030-8","article-title":"Lipoprotein metabolism and renal failure","volume":"21","author":"Attman","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"B41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy","volume":"55","author":"Herman-Edelstein","year":"2013","journal-title":"J Lipid Res"},{"issue":"83\u00e2\u20ac\u201c98","key":"B42","first-page":"87","article-title":"Intercapillary lesions in the glomeruli of the kidney","volume":"12","author":"Kimmelstiel","year":"1936","journal-title":"Am J Pathol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0140-6736(82)91513-6","article-title":"Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease","volume":"2","author":"Moorhead","year":"1982","journal-title":"Lancet"},{"key":"B44","first-page":"S69","article-title":"Lipids and the progression of renal disease","volume":"1","author":"Keane","year":"1990","journal-title":"J Am Soc Nephrol"},{"key":"B45","doi-asserted-by":"crossref","first-page":"10048","DOI":"10.1016\/S0021-9258(19)70424-4","article-title":"Biosynthesis of apolipoprotein B in rooster kidney, intestine, and liver","volume":"255","author":"Blue","year":"1980","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"crossref","first-page":"11151","DOI":"10.1016\/S0021-9258(18)33945-0","article-title":"Synthesis of apolipoprotein AI by peripheral tissues of the rooster. A possible mechanism of cellular cholesterol efflux","volume":"257","author":"Blue","year":"1982","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0022-2275(20)32562-1","article-title":"Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney","volume":"39","author":"Tarugi","year":"1998","journal-title":"J Lipid Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"31286","DOI":"10.1074\/jbc.274.44.31286","article-title":"A novel human apolipoprotein (apoM)","volume":"274","author":"Xu","year":"1999","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1073\/pnas.80.1.283","article-title":"Apolipoprotein E synthesis in human kidney, adrenal gland, and liver","volume":"80","author":"Blue","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/ki.1990.135","article-title":"Receptor mediated uptake of apo B and apo E rich lipoproteins by human glomerular epithelial cells","volume":"37","author":"Gr\u00c3\u00b6ne","year":"1990","journal-title":"Kidney Int"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1681\/ASN.2011010069","article-title":"APOL1 localization in normal kidney and nondiabetic kidney disease","volume":"22","author":"Madhavan","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"B52","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.2337\/db13-0399","article-title":"Cyclodextrin protects podocytes in diabetic kidney disease","volume":"62","author":"Merscher-Gomez","year":"2013","journal-title":"Diabetes"},{"key":"B53","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/jhg.2013.8","article-title":"A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy","volume":"58","author":"Toyota","year":"2013","journal-title":"J Hum Genet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1046\/j.1523-1755.1999.00572.x","article-title":"A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy","volume":"56","author":"Matsunaga","year":"1999","journal-title":"Kidney Int"},{"key":"B55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1050-1738(01)00148-7","article-title":"Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy","volume":"12","author":"Saito","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0272-6386(12)81066-3","article-title":"Lipoprotein glomerulopathy: first report in a Chinese male","volume":"24","author":"Zhang","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"B57","first-page":"51","article-title":"Type 3 hyperlipoproteinemia with mesangial foam cells in renal glomeruli","volume":"98","author":"Amatruda","year":"1974","journal-title":"Arch Pathol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1046\/j.1523-1755.2001.0590051911.x","article-title":"Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity","volume":"59","author":"Sakatsume","year":"2001","journal-title":"Kidney Int"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1194\/jlr.M500114-JLR200","article-title":"The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor","volume":"46","author":"Ruiz","year":"2005","journal-title":"J Lipid Res"},{"key":"B60","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0021-9150(94)90021-3","article-title":"Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus","volume":"107","author":"Horita","year":"1994","journal-title":"Atherosclerosis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000045517","article-title":"Apolipoprotein E polymorphism in IgA nephropathy","volume":"83","author":"Yorioka","year":"1999","journal-title":"Nephron"},{"key":"B62","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1053\/ajkd.1998.v31.pm9531184","article-title":"Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM","volume":"31","author":"Kimura","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1073\/pnas.89.10.4471","article-title":"Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells","volume":"89","author":"Piedrahita","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B64","first-page":"281","article-title":"A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia","volume":"58","author":"Feussner","year":"1996","journal-title":"Am J Hum Genet"},{"key":"B65","doi-asserted-by":"publisher","first-page":"31269","DOI":"10.1074\/jbc.M005906200","article-title":"Virus-mediated transduction of apolipoprotein E (ApoE)-sendai develops lipoprotein glomerulopathy in ApoE-deficient mice","volume":"275","author":"Ishigaki","year":"2000","journal-title":"J Biol Chem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1097\/01.LAB.0000022222.03120.D4","article-title":"Renal injury in apolipoprotein E-deficient mice","volume":"82","author":"Wen","year":"2002","journal-title":"Lab Invest"},{"key":"B67","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s10157-009-0195-1","article-title":"Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice","volume":"13","author":"Ishimura","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2005.07.017","article-title":"Severe hyperlipidemia causes impaired renin-angiotensin system function in apolipoprotein E deficient mice","volume":"186","author":"Mazzolai","year":"2006","journal-title":"Atherosclerosis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/ndt\/17.12.2099","article-title":"Mesangial expansion associated with glomerular endothelial cell activation and macrophage recruitment is developing in hyperlipidaemic apoE null mice","volume":"17","author":"Bruneval","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1097\/01.ASN.0000133025.23732.46","article-title":"Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products","volume":"15","author":"Lassila","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ajpath.2011.04.029","article-title":"Deficiency of a transcriptional regulator, inhibitor of differentiation 3, induces glomerulonephritis in apolipoprotein E-deficient mice: a model linking hyperlipidemia and renal disease","volume":"179","author":"Bagavant","year":"2011","journal-title":"Am J Pathol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1194\/jlr.M600512-JLR200","article-title":"ApoE-\/-Fas-\/- C57BL\/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia","volume":"48","author":"Feng","year":"2007","journal-title":"J Lipid Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"F653","DOI":"10.1152\/ajprenal.90668.2008","article-title":"Human immunodeficiency virus downregulates podocyte apoE expression","volume":"297","author":"Arora","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"B74","first-page":"1804","article-title":"Renal apolipoproteins in nephrotic rats","volume":"142","author":"van Goor","year":"1993","journal-title":"Am J Pathol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1046\/j.1523-1755.2003.00777.x","article-title":"Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis","volume":"63","author":"Bruschi","year":"2003","journal-title":"Kidney Int"},{"key":"B76","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1210\/me.2005-0209","article-title":"Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M","volume":"20","author":"Faber","year":"2006","journal-title":"Mol Endocrinol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0002-9440(10)65238-8","article-title":"Megalin knockout mice as an animal model of low molecular weight proteinuria","volume":"155","author":"Leheste","year":"1999","journal-title":"Am J Pathol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e25065","DOI":"10.1371\/journal.pone.0025065","article-title":"Receptor-mediated endocytosis of alpha-galactosidase A in human podocytes in Fabry disease","volume":"6","author":"Prabakaran","year":"2011","journal-title":"PLoS One"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1172\/JCI119768","article-title":"Pathogenic antibodies inhibit the binding of apolipoproteins to megalin\/gp330 in passive Heymann nephritis","volume":"100","author":"Kerjaschki","year":"1997","journal-title":"J Clin Invest"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"B82","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"B83","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/0005-2760(67)90064-1","article-title":"Familial serum-cholesterol esterification failure. A new inborn error of metabolism","volume":"144","author":"Norum","year":"1967","journal-title":"Biochim Biophys Acta"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1172\/JCI107273","article-title":"Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency. Further studies of very low and low density lipoprotein abnormalities","volume":"52","author":"Glomset","year":"1973","journal-title":"J Clin Invest"},{"key":"B85","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0272-6386(86)80055-5","article-title":"Nephropathy of familial lecithin-cholesterol acyltransferase deficiency: report of a case","volume":"7","author":"Ohta","year":"1986","journal-title":"Am J Kidney Dis"},{"key":"B86","first-page":"411","article-title":"Renal failure in familial lecithin: cholesterol acyltransferase deficiency","volume":"51","author":"Borysiewicz","year":"1982","journal-title":"Q J Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0005-2760(72)90082-3","article-title":"Structure of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice","volume":"260","author":"Seidel","year":"1972","journal-title":"Biochim Biophys Acta"},{"key":"B88","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0014-5793(72)80758-0","article-title":"Identification of the abnormal cholestatic lipoprotein (LP-X) in familial lecithin:cholesterol acyltransferase deficiency","volume":"24","author":"Torsvik","year":"1972","journal-title":"FEBS Lett"},{"key":"B89","doi-asserted-by":"publisher","first-page":"9397","DOI":"10.1093\/nar\/14.23.9397","article-title":"Human lecithin-cholesterol acyltransferase gene: complete gene sequence and sites of expression","volume":"14","author":"McLean","year":"1986","journal-title":"Nucleic Acids Res"},{"key":"B90","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0378-1119(93)90578-Q","article-title":"Baboon lecithin cholesterol acyltransferase (LCAT): cDNA sequences of two alleles, evolution, and gene expression","volume":"128","author":"Hixson","year":"1993","journal-title":"Gene"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2014.07.011","article-title":"Characteristic, polymorphism and expression distribution of LCAT gene in a Mongolian gerbil model for hyperlipidemia","author":"Liu","year":"2014","journal-title":"Exp Mol Pathol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"7506","DOI":"10.1074\/jbc.272.11.7506","article-title":"Targeted disruption of the mouse lecithin:cholesterol acyltransferase (LCAT) gene. Generation of a new animal model for human LCAT deficiency","volume":"272","author":"Sakai","year":"1997","journal-title":"J Biol Chem"},{"key":"B93","doi-asserted-by":"publisher","first-page":"15777","DOI":"10.1074\/jbc.272.25.15777","article-title":"Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I","volume":"272","author":"Ng","year":"1997","journal-title":"J Biol Chem"},{"key":"B94","doi-asserted-by":"publisher","first-page":"15090","DOI":"10.1074\/jbc.M008466200","article-title":"Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice","volume":"276","author":"Lambert","year":"2001","journal-title":"J Biol Chem"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0002-9440(10)63386-X","article-title":"A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy","volume":"165","author":"Zhu","year":"2004","journal-title":"Am J Pathol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0962-8924(94)90086-8","article-title":"The NP-C gene: a key to pathways of intracellular cholesterol transport","volume":"4","author":"Pentchev","year":"1994","journal-title":"Trends Cell Biol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.1073\/pnas.82.23.8247","article-title":"A defect in cholesterol esterification in Niemann-Pick disease (type C) patients","volume":"82","author":"Pentchev","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B98","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1126\/science.277.5323.232","article-title":"Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene","volume":"277","author":"Loftus","year":"1997","journal-title":"Science"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e77586","DOI":"10.1371\/journal.pone.0077586","article-title":"Characterization of Niemann-Pick Type C2 protein expression in multiple cancers using a novel NPC2 monoclonal antibody","volume":"8","author":"Liao","year":"2013","journal-title":"PLoS One"},{"key":"B100","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/ndtplus\/sfp101","article-title":"Renal involvement in Neimann-pick disease","volume":"2","author":"Grafft","year":"2009","journal-title":"NDT Plus"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/ndt\/17.10.1829","article-title":"Membranoproliferative glomerulonephritis type II and Niemann-Pick disease type C","volume":"17","author":"Philit","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1073\/pnas.0810895106","article-title":"Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-\/- mouse","volume":"106","author":"Liu","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B103","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1203\/00006450-201011001-00604","article-title":"Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life","volume":"68","author":"Ramirez","year":"2010","journal-title":"Pediatr Res"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e6951","DOI":"10.1371\/journal.pone.0006951","article-title":"Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression","volume":"4","author":"Davidson","year":"2009","journal-title":"PLoS One"},{"key":"B105","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0021-9150(99)00498-0","article-title":"Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations","volume":"152","author":"Mott","year":"2000","journal-title":"Atherosclerosis"},{"key":"B106","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/11914","article-title":"The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease","volume":"22","author":"Bodzioch","year":"1999","journal-title":"Nat Genet"},{"key":"B107","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/11905","article-title":"Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency","volume":"22","author":"Brooks-Wilson","year":"1999","journal-title":"Nat Genet"},{"key":"B108","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/11921","article-title":"Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1","volume":"22","author":"Rust","year":"1999","journal-title":"Nat Genet"},{"key":"B109","first-page":"101","article-title":"The pathology of Tangier disease. A light and electron microscopic study","volume":"78","author":"Ferrans","year":"1975","journal-title":"Am J Pathol"},{"key":"B110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcp\/98.2.191","article-title":"The heart in Tangier disease. Severe coronary atherosclerosis with near absence of high-density lipoprotein cholesterol","volume":"98","author":"Mautner","year":"1992","journal-title":"Am J Clin Pathol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0002-9440(10)64614-7","article-title":"Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency","volume":"157","author":"Christiansen-Weber","year":"2000","journal-title":"Am J Pathol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/72869","article-title":"Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice","volume":"24","author":"Ors\u00c3\u00b3","year":"2000","journal-title":"Nat Genet"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.2337\/db05-0603","article-title":"Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes","volume":"55","author":"Proctor","year":"2006","journal-title":"Diabetes"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1177\/1470320313507123","article-title":"Protective effects of aliskiren and valsartan in mice with diabetic nephropathy","author":"Wang","year":"2014","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"B115","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.2337\/diabetes.54.8.2328","article-title":"Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb\/db mice with type 2 diabetes","volume":"54","author":"Wang","year":"2005","journal-title":"Diabetes"},{"key":"B116","doi-asserted-by":"publisher","first-page":"592576","DOI":"10.1155\/2013\/592576","article-title":"Cholesterol contributes to diabetic nephropathy through SCAP-SREBP-2 pathway","volume":"2013","author":"Sun","year":"2013","journal-title":"Int J Endocrinol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/jcp.21316","article-title":"A model for diabetic nephropathy: advantages of the inducible cAMP early repressor transgenic mouse over the streptozotocin-induced diabetic mouse","volume":"215","author":"Inada","year":"2008","journal-title":"J Cell Physiol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1440-1797.2007.00796.x","article-title":"Rodent models of streptozotocin-induced diabetic nephropathy (methods in renal research)","volume":"12","author":"Tesch","year":"2007","journal-title":"Nephrology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/dmrr.472","article-title":"Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model","volume":"20","author":"Palm","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1194\/jlr.M003525","article-title":"Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys","volume":"51","author":"Tang","year":"2009","journal-title":"J Lipid Res"},{"key":"B121","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1172\/JCI17867","article-title":"Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions","volume":"114","author":"Renard","year":"2004","journal-title":"J Clin Invest"},{"key":"B122","doi-asserted-by":"publisher","first-page":"F600","DOI":"10.1152\/ajprenal.00289.2005","article-title":"Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy","volume":"290","author":"Agarwal","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1053\/j.ajkd.2009.03.022","article-title":"Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the collaborative atorvastatin diabetes study (CARDS)","volume":"54","author":"Colhoun","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"B124","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1681\/ASN.2013090965","article-title":"Effects of lowering LDL cholesterol on progression of kidney disease","volume":"25","author":"Haynes","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbagen.2009.10.009","article-title":"Niacin improves renal lipid metabolism and slows progression in chronic kidney disease","volume":"1800","author":"Cho","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"B126","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000210020","article-title":"Reverse cholesterol transport pathway in experimental chronic renal failure","volume":"30","author":"Moradi","year":"2009","journal-title":"Am J Nephrol"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.2215\/CJN.02440311","article-title":"HMG-CoA reductase activation and urinary pellet cholesterol elevations in acute kidney injury","volume":"6","author":"Johnson","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1046\/j.1523-1755.2001.00071.x","article-title":"Renal cortical cholesterol accumulation is an integral component of the systemic stress response","volume":"60","author":"Zager","year":"2001","journal-title":"Kidney Int"},{"key":"B129","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0002-9440(10)61745-2","article-title":"Renal cholesterol accumulation: a durable response after acute and subacute renal insults","volume":"159","author":"Zager","year":"2001","journal-title":"Am J Pathol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0002-9440(10)63819-9","article-title":"Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression","volume":"162","author":"Johnson","year":"2003","journal-title":"Am J Pathol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/0014-4800(77)90035-1","article-title":"Saturated free fatty acid toxicity. II. lipid accumulation, ultrastructural alterations, and toxicity in mammalian cells in culture","volume":"27","author":"Gordon","year":"1977","journal-title":"Exp Mol Pathol"},{"key":"B132","first-page":"663","article-title":"Lipid accumulation of hypoxic tissue culture cells","volume":"88","author":"Gordon","year":"1977","journal-title":"Am J Pathol"},{"key":"B133","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/S0021-9258(17)34720-8","article-title":"Control of fatty acid metabolism in ischemic and hypoxic hearts","volume":"253","author":"Whitmer","year":"1978","journal-title":"J Biol Chem"},{"key":"B134","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jhep.2011.04.022","article-title":"Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese","volume":"56","author":"Aron-Wisnewsky","year":"2011","journal-title":"J Hepatol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1161\/01.ATV.0000229665.78997.0b","article-title":"Hypoxia converts human macrophages into triglyceride-loaded foam cells","volume":"26","author":"Bostr\u00c3\u00b6m","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1042\/CS20090565","article-title":"Hypoxia and non-alcoholic fatty liver disease","volume":"118","author":"Byrne","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jacc.2007.12.025","article-title":"Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis","volume":"51","author":"Sluimer","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","article-title":"HIF-1alpha is essential for myeloid cell-mediated inflammation","volume":"112","author":"Cramer","year":"2003","journal-title":"Cell"},{"key":"B139","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/path.1778","article-title":"Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1)","volume":"206","author":"Greijer","year":"2005","journal-title":"J Pathol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1182\/blood-2004-07-2958","article-title":"Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1","volume":"105","author":"Manalo","year":"2005","journal-title":"Blood"},{"key":"B141","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature04871","article-title":"Hypoxia signalling in cancer and approaches to enforce tumour regression","volume":"441","author":"Pouyssegur","year":"2006","journal-title":"Nature"},{"key":"B142","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm0603-677","article-title":"Regulation of angiogenesis by hypoxia: role of the HIF system","volume":"9","author":"Pugh","year":"2003","journal-title":"Nat Med"},{"key":"B143","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3727\/000000003108749062","article-title":"Gene expression profiling of the hypoxia signaling pathway in hypoxia-inducible factor 1alpha null mouse embryonic fibroblasts","volume":"11","author":"Vengellur","year":"2003","journal-title":"Gene Expr"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1096\/fj.01-0944rev","article-title":"Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression","volume":"16","author":"Wenger","year":"2002","journal-title":"FASEB J"},{"key":"B145","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.imbio.2011.12.003","article-title":"The polysaccharide fraction of Propionibacterium acnes modulates the development of experimental focal segmental glomerulosclerosis","volume":"217","author":"Reis","year":"2011","journal-title":"Immunobiology"},{"key":"B146","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/ki.2011.14","article-title":"Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis","volume":"79","author":"Pereira","year":"2011","journal-title":"Kidney Int"},{"key":"B147","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/jcb.21757","article-title":"Regulation of HMG-CoA reductase expression by hypoxia","volume":"104","author":"Pallottini","year":"2008","journal-title":"J Cell Biochem"},{"key":"B148","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1128\/MCB.00200-09","article-title":"Hypoxia-inducible factor 2 regulates hepatic lipid metabolism","volume":"29","author":"Rankin","year":"2009","journal-title":"Mol Cell Biol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1096\/fj.10-159806","article-title":"Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1","volume":"24","author":"Gimm","year":"2010","journal-title":"FASEB J"},{"key":"B150","doi-asserted-by":"publisher","first-page":"F271","DOI":"10.1152\/ajprenal.00071.2006","article-title":"Hypoxia-inducible factors in the kidney","volume":"291","author":"Haase","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/01.ASN.0000059308.82322.4F","article-title":"Podocyte expression of hypoxia-inducible factor (HIF)-1 and HIF-2 during glomerular development","volume":"14","author":"Freeburg","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1681\/ASN.2006060639","article-title":"Protective role of hypoxia-inducible factor-2alpha against ischemic damage and oxidative stress in the kidney","volume":"18","author":"Kojima","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1097\/01.ASN.0000074239.22357.06","article-title":"Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats","volume":"14","author":"Matsumoto","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1681\/ASN.2007040419","article-title":"HIF activation protects from acute kidney injury","volume":"19","author":"Weidemann","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/ncpneph0757","article-title":"Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy","volume":"4","author":"Singh","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"B156","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","article-title":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis","volume":"52","author":"Musso","year":"2012","journal-title":"Prog Lipid Res"},{"key":"B157","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/hep.22423","article-title":"Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice","volume":"48","author":"Ma","year":"2008","journal-title":"Hepatology"},{"key":"B158","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1681\/ASN.2011060628","article-title":"Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes","volume":"23","author":"Gohda","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2215\/CJN.03010608","article-title":"Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes","volume":"4","author":"Niewczas","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1681\/ASN.2011060627","article-title":"Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes","volume":"23","author":"Niewczas","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11010-010-0605-4","article-title":"Interleukin-1beta enhances the intracellular accumulation of cholesterol by up-regulating the expression of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase in podocytes","volume":"346","author":"Zhang","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"B162","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1046\/j.1523-1755.2001.00025.x","article-title":"Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation","volume":"60","author":"Ruan","year":"2001","journal-title":"Kidney Int"},{"key":"B163","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.ASN.0000050414.52908.DA","article-title":"PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway","volume":"14","author":"Ruan","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"F680","DOI":"10.1152\/ajprenal.00209.2007","article-title":"Inflammatory cytokines disrupt LDL-receptor feedback regulation and cause statin resistance: a comparative study in human hepatic cells and mesangial cells","volume":"293","author":"Chen","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/ki.2013.503","article-title":"Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation","volume":"85","author":"Bakker","year":"2014","journal-title":"Kidney Int"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T23:17:15Z","timestamp":1650410235000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2014.00169\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,14]]},"references-count":165,"URL":"https:\/\/doi.org\/10.3389\/fendo.2014.00169","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,14]]}}}